WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,450.00
+30.00 (0.40%)
At close: Aug 28, 2025
0.40%
Market Cap98.36B
Revenue (ttm)102.49B
Net Income (ttm)5.98B
Shares Out13.20M
EPS (ttm)453.76
PE Ratio16.42
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume67,023
Average Volume34,991
Open7,330.00
Previous Close7,420.00
Day's Range7,330.00 - 7,510.00
52-Week Range5,610.00 - 10,450.00
Beta0.75
RSI51.13
Earnings DateMar 14, 2025

About KOSDAQ:330350

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name... [Read more]

Industry Pharmaceutical Preparations
Founded 2004
Employees 121
Stock Exchange KOSDAQ
Ticker Symbol 330350
Full Company Profile

Financial Performance

In 2024, KOSDAQ:330350's revenue was 102.72 billion, an increase of 28.21% compared to the previous year's 80.12 billion. Earnings were 4.78 billion, a decrease of -39.88%.

Financial Statements

News

There is no news available yet.